concise.news
SearchSign inGet the Brief
Story
‹ Story 8

Story tools

FDA warns GLP-1 weight loss medications can cause rare blindness-causing eye condition.

Compare

How each outlet told it.

  1. SourceCBS NewsUnited StatesLeanUnratedCredibilityUnratedRead at CBS News“FDA warns of rare vision-loss side effect from GLP-1 drugs”10 h 9 min later
  2. SourceMintIndiaOwner: HT MediaLeanCenterCredibilityRatings: AllSides, MBFCRead at Mint“FDA flags potential vision loss risk linked to GLP-1 drugs: What users of weight-loss medications should know”4 h 25 min later
  3. SourceArs TechnicaUnited StatesLeanCenter-leftCredibilityRatings: AllSides, MBFCRead at Ars Technica“GLP-1 drugs may increase risk of vision loss from rare condition, FDA warns”39 min later
  4. SourceThe IndependentUnited KingdomLeanCenter-leftCredibilityRatings: AllSides, MBFCRead at The Independent“FDA adds rare blindness warning to popular GLP-1 drugs”1 h 37 min later
  5. SourceThe NationalUnited Arab EmiratesLeanUnratedCredibilityUnratedRead at The National“FDA orders new warning on GLP-1 drugs over potential risk of blindness”1 h 18 min later
  6. SourceGlobal NewsCanadaOwner: Global Television NetworkLeanUnratedCredibilityUnratedRead at Global News“FDA to require vision loss warning on GLP-1 drug labels”25 min later
  7. SourceBBCUnited KingdomOwner: British Broadcasting CorporationLeanCenterCredibilityRatings: AllSides, MBFCRead at BBC“Makers of GLP-1 drugs ordered to add warnings about rare eye condition that can lead to blindness”1 h 35 min later
  8. SourceThe GuardianUnited KingdomOwner: Guardian Media GroupLeanCenter-leftCredibilityRatings: AllSides, MBFCRead at The Guardian“FDA warns of rare eye condition causing blindness from GLP-1 weight loss medications”10 h 43 min later
  9. SourceBusinessLineIndiaLeanUnratedCredibilityUnratedRead at BusinessLine“FDA flags possible risk of rare eye condition with GLP-1 drugs, orders new safety warning”

In both headlinesTimes in UTC

Another view

Reliable reporting from a different lean.

No other view yet. Only center-left and center outlets are covering this story.

RatingsAllSides and Media Bias/Fact CheckLean and credibility are curated from their public ratings.Unknown outlets stay unrated, never guessed.

Citations

What it cites, and what cites it.

None.

Corrections

None.

Mentioned with

Nothing yet.

How each outlet told it.

  1. SourceCBS NewsUnited StatesLeanUnratedCredibilityUnratedRead at CBS News“FDA warns of rare vision-loss side effect from GLP-1 drugs”10 h 9 min later
  2. SourceMintIndiaOwner: HT MediaLeanCenterCredibilityRatings: AllSides, MBFCRead at Mint“FDA flags potential vision loss risk linked to GLP-1 drugs: What users of weight-loss medications should know”4 h 25 min later
  3. SourceArs TechnicaUnited StatesLeanCenter-leftCredibilityRatings: AllSides, MBFCRead at Ars Technica“GLP-1 drugs may increase risk of vision loss from rare condition, FDA warns”39 min later
  4. SourceThe IndependentUnited KingdomLeanCenter-leftCredibilityRatings: AllSides, MBFCRead at The Independent“FDA adds rare blindness warning to popular GLP-1 drugs”1 h 37 min later
  5. SourceThe NationalUnited Arab EmiratesLeanUnratedCredibilityUnratedRead at The National“FDA orders new warning on GLP-1 drugs over potential risk of blindness”1 h 18 min later
  6. SourceGlobal NewsCanadaOwner: Global Television NetworkLeanUnratedCredibilityUnratedRead at Global News“FDA to require vision loss warning on GLP-1 drug labels”25 min later
  7. SourceBBCUnited KingdomOwner: British Broadcasting CorporationLeanCenterCredibilityRatings: AllSides, MBFCRead at BBC“Makers of GLP-1 drugs ordered to add warnings about rare eye condition that can lead to blindness”1 h 35 min later
  8. SourceThe GuardianUnited KingdomOwner: Guardian Media GroupLeanCenter-leftCredibilityRatings: AllSides, MBFCRead at The Guardian“FDA warns of rare eye condition causing blindness from GLP-1 weight loss medications”10 h 43 min later
  9. SourceBusinessLineIndiaLeanUnratedCredibilityUnratedRead at BusinessLine“FDA flags possible risk of rare eye condition with GLP-1 drugs, orders new safety warning”

In both headlinesTimes in UTC